Plasma Fractionation Market Size Analysis, Drivers, Restraints, Key Factors Forecast, 2030

The Plasma Fractionation Market report by MarkNtel Advisors – Market Research Company, offers a comprehensive analysis of the current state of the market, including an overview of key players, emerging trends, and future growth prospects. The report is segmented into various sections, each dedicated to different aspects of the market such as market size, geographical shares, competitive landscape, and market dynamics.

How Big is the Plasma Fractionation Industry?

The Global Plasma Fractionation Market size is expected to rise at a CAGR of around 7.1% during the forecast period 2024-2030.

Explore What This Report Can Do for You: Download Free Sample [PDF, Excel, PPT] of the Report: – https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

Plasma Fractionation Market Trend:

Expansion of Plasma Fractionation Plants Gaining Traction – The growing positive outcomes of plasma-derived drugs for chronic, autoimmune, and other diseases have raised the demand for plasma fractionation products in the market. The booming demand for plasma fractionation products has prompted global players in the Plasma Fractionation Market, such as Takeda Pharmaceuticals and Grifols, to embark on a trend of establishing new manufacturing facilities worldwide. For instance:

• In 2022, Takeda announced an investment of nearly USD 300 million to construct a new production facility and a warehouse for plasma-derived therapies in Belgium.

This decision aligned with the increasing need for therapeutic drugs produced through plasma fractionation, such as immunoglobulin, albumin, and others, to meet rising demand. As a result, this new trend would allow companies to cater to a wider audience range across different countries, which would further support their growth in the coming years as well.

Competitor Breakdown: Top Plasma Fractionation Companies 2024-2030

• Biotest A.G.

• Octapharma A.G.

• Adma Biologics

• Aegros

• CSL Limited

• Grifols S.A.

• Kedrion Biopharma Inc.

• Bio Products Laboratory Ltd

• Takeda Pharmaceuticals

• Emergent Bio solutions

• Intas Pharmaceutical

• Plasma Gen Biosciences

• S K Plasma

• Australian Red Cross Lifeblood

Note: If additional specific information is required beyond the current scope of the report, we will gladly provide it as part of the customization process.

Customization Requests can be Sent Directly to:- https://www.marknteladvisors.com/query/request-customization/plasma-fractionation-market.html

Regional Analysis:

North America, Europe, Asia Pacific, Middle East & Africa, and South America

• Share of each region segment in the Market

• Potential growth opportunities in the region

• The growth rate of the region in the Industry

Breaking Down the Plasma Fractionation Market Segmentation:

By Product

• Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)

  • Intravenous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)

  • Subcutaneous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)

  • Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2019-2030, (USD Million)

• Coagulation Factors- Market Size & Forecast 2019-2030, (USD Million)

  • Factor VIII- Market Size & Forecast 2019-2030, (USD Million)

  • Factor IX- Market Size & Forecast 2019-2030, (USD Million)

  • Von Willebrand Factor (vWF) - Market Size & Forecast 2019-2030, (USD Million)

  • Prothrombin Complex Concentrates- Market Size & Forecast 2019-2030, (USD Million)

  • Fibrinogen Concentrates- Market Size & Forecast 2019-2030, (USD Million)

  • Factor XIII- Market Size & Forecast 2019-2030, (USD Million)

  • Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2019-2030, (USD Million)

• Albumin- Market Size & Forecast 2019-2030, (USD Million)

• Protease Inhibitor- Market Size & Forecast 2019-2030, (USD Million)

• Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2019-2030, (USD Million)

By Application

• Neurology- Market Size & Forecast 2019-2030, (USD Million)

• Immunology- Market Size & Forecast 2019-2030, (USD Million)

• Hematology- Market Size & Forecast 2019-2030, (USD Million)

• Critical Care- Market Size & Forecast 2019-2030, (USD Million)

• Pulmonology- Market Size & Forecast 2019-2030, (USD Million)

• Rheumatology- Market Size & Forecast 2019-2030, (USD Million)

• Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2019-2030, (USD Million)

By End User

• Hospitals - Market Size & Forecast 2019-2030, (USD Million)

• Specialty Clinics- Market Size & Forecast 2019-2030, (USD Million)

• Research Facilities - Market Size & Forecast 2019-2030, (USD Million)

Why This Report:

• We offer strategic insights and data analytics across 80+ countries, empowering clients to make informed decisions.

• Specializing in niche industries and emerging markets, we help clients identify investment opportunities and maximize ROI.

• With a global presence and expertise in 15 industry verticals, we deliver comprehensive market research for top multinational firms.

• Our skilled team provides in-depth qualitative and quantitative research, ensuring detailed and valuable market insights.

• We support clients with Go-to-Market strategies, competitive benchmarking, market sizing, and trend analysis to drive strategic growth.

For Purchase Enquiry or Further Discussion

Connect with our skilled team of analysts and industry experts. We'll work closely with you to understand your business challenges and goals. Together, we'll find unique solutions using simple, effective strategies. [Contact Us Today]

About US

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact: 

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India